ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för PJ34. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

44 träffar

Bibliografisk träff 2012-04-28

Unusual increase in lumbar network excitability of the rat spinal cord evoked by the PARP-1 inhibitor PJ-34 through inhibition of glutamate uptake.

Nasrabady SE, Kuzhandaivel A, Akrami A, Bianchetti E, Milanese M, Bonanno G, Nistri A.

Neuropharmacology · research support, non-u.s. gov't; journal article · DOI 10.1016/j.neuropharm.2012.04.014

Bibliografisk träff 2012-01-21

Structure of human tankyrase 1 in complex with small-molecule inhibitors PJ34 and XAV939.

Kirby CA, Cheung A, Fazal A, Shultz MD, Stams T.

Acta Crystallogr Sect F Struct Biol Cryst Commun · research support, non-u.s. gov't; research-article; research support, u.s. gov't, non-p.h.s.; journal article; research support, n.i.h., extramural · DOI 10.1107/s1744309111051219

Bibliografisk träff 2011-05-30

Studies of locomotor network neuroprotection by the selective poly(ADP-ribose) polymerase-1 inhibitor PJ-34 against excitotoxic injury to the rat spinal cord in vitro.

Nasrabady SE, Kuzhandaivel A, Nistri A.

Eur J Neurosci · research support, non-u.s. gov't; journal article · DOI 10.1111/j.1460-9568.2011.07714.x

Bibliografisk träff 2010-12-29

Effect of the PARP-1 inhibitor PJ 34 on excitotoxic damage evoked by kainate on rat spinal cord organotypic slices.

Mazzone GL, Nistri A.

Cell Mol Neurobiol · research support, non-u.s. gov't; research-article; journal article · DOI 10.1007/s10571-010-9640-7

Bibliografisk träff 2010-02-01

Inhibition of PARP activity by PJ-34 leads to growth impairment and cell death associated with aberrant mitotic pattern and nucleolar actin accumulation in M14 melanoma cell line.

Chevanne M, Zampieri M, Caldini R, Rizzo A, Ciccarone F, Catizone A, D'Angelo C, Guastafierro T, Biroccio A, Reale A, Zupi G, Caiafa P.

J Cell Physiol · research support, non-u.s. gov't; journal article · DOI 10.1002/jcp.21964

Bibliografisk träff 2009-05-01

Structural basis for inhibitor specificity in human poly(ADP-ribose) polymerase-3.

Lehtiö L, Jemth AS, Collins R, Loseva O, Johansson A, Markova N, Hammarström M, Flores A, Holmberg-Schiavone L, Weigelt J, Helleday T, Schüler H, Karlberg T.

J Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1021/jm900052j

Bibliografisk träff 2008-09-01

PJ34, an inhibitor of PARP-1, suppresses cell growth and enhances the suppressive effects of cisplatin in liver cancer cells.

Huang SH, Xiong M, Chen XP, Xiao ZY, Zhao YF, Huang ZY.

Oncol Rep · research support, non-u.s. gov't; journal article · DOI 10.3892/or_00000043

Bibliografisk träff 2008-07-01

Inhibition of angiogenesis by the poly(ADP-ribose) polymerase inhibitor PJ-34.

Pyriochou A, Olah G, Deitch EA, Szabó C, Papapetropoulos A.

Int J Mol Med · research support, non-u.s. gov't; journal article; research support, n.i.h., extramural · DOI 10.3892/ijmm.22.1.113

Bibliografisk träff 2008-02-14

Cholix toxin, a novel ADP-ribosylating factor from Vibrio cholerae.

Jørgensen R, Purdy AE, Fieldhouse RJ, Kimber MS, Bartlett DH, Merrill AR.

J Biol Chem · research support, non-u.s. gov't; journal article; research support, n.i.h., extramural · DOI 10.1074/jbc.m710008200

Bibliografisk träff 2007-07-05

Effect of PJ-34 PARP-inhibitor on rat liver microcirculation and antioxidant status.

Szijártó A, Batmunkh E, Hahn O, Mihály Z, Kreiss A, Kiss A, Lotz G, Schaff Z, Váli L, Blázovics A, Geró D, Szabó C, Kupcsulik P.

J Surg Res · research support, non-u.s. gov't; journal article · DOI 10.1016/j.jss.2006.08.003

Bibliografisk träff 2005-08-01

Exotoxin A-eEF2 complex structure indicates ADP ribosylation by ribosome mimicry.

Jørgensen R, Merrill AR, Yates SP, Marquez VE, Schwan AL, Boesen T, Andersen GR.

Nature · research support, non-u.s. gov't; research support, u.s. gov't, non-p.h.s.; journal article · DOI 10.1038/nature03871

Bibliografisk träff 2005-02-01

Structure-function analysis of water-soluble inhibitors of the catalytic domain of exotoxin A from Pseudomonas aeruginosa.

Yates SP, Taylor PL, Jørgensen R, Ferraris D, Zhang J, Andersen GR, Merrill AR.

Biochem J · research support, non-u.s. gov't; research-article; journal article · DOI 10.1042/bj20041480

Bibliografisk träff 2002-02-01

Myocardial protection by PJ34, a novel potent poly (ADP-ribose) synthetase inhibitor.

Faro R, Toyoda Y, McCully JD, Jagtap P, Szabo E, Virag L, Bianchi C, Levitsky S, Szabo C, Sellke FW.

Ann Thorac Surg · research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; journal article · DOI 10.1016/s0003-4975(01)03329-x

Bibliografisk träff 2001-03-01

Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke.

Abdelkarim GE, Gertz K, Harms C, Katchanov J, Dirnagl U, Szabó C, Endres M.

Int J Mol Med · research support, u.s. gov't, p.h.s.; journal article · DOI 10.3892/ijmm.7.3.255